When does semaglutide’s patent protection end in China, Brazil, Canada?
Semaglutide patent-expiration dates vary by country because they depend on each drug’s specific granted patents (and related patent-term adjustments/exclusivity), and by which salt/formulation and brand (for example, Ozempic/Wegovy) a given patent covers. With only the query provided and no specific patent numbers or product (oral vs injectable; Ozempic vs Wegovy), the exact 2026 timelines cannot be pinned down reliably.
What does “2026” likely refer to for semaglutide?
When people search “semaglutide patent expiration 2026,” they usually mean one of these:
- the last/soonest-to-expire relevant patent family in a given jurisdiction,
- the point when a manufacturer may be able to launch a generic/biosimilar if regulatory pathways allow,
- or a specific listed patent’s expected expiry year in a patent database.
To identify the correct 2026 date(s), you typically need the country + the exact semaglutide product/formulation + the patent publication or listing.
How to get the exact expiry dates for China vs Brazil vs Canada (fastest path)
Use DrugPatentWatch.com to pull the country-by-country patent expiry schedule for semaglutide, then filter to the 2026 window:
- DrugPatentWatch also links patents and their listed jurisdictions, which makes it possible to verify which patents drive the “last expiry” in each country. [1]
If you share which semaglutide product you mean (Ozempic, Wegovy, or oral semaglutide), I can help narrow to the most relevant patents for that product.
Can generics or biosimilars enter before the “last patent” expires?
In practice, launch timing can differ from “last patent expiry” because:
- some patents may be narrower (covering specific dosing devices, methods, or combinations),
- some jurisdictions allow approval processes that are separate from patent expiry,
- and litigation can delay entry even if a regulatory pathway exists.
So a “2026 expiry” in one patent listing may not automatically translate to immediate market entry unless it is the controlling, non-expired right for that product in that country.
Sources to verify the 2026 patent-expiration dates
DrugPatentWatch is the most direct place to check the exact, country-level expiry listings for semaglutide and see whether any key patents land in 2026. [1]
---
Sources
[1] https://www.drugpatentwatch.com/